Boku N - Search Results

1

Current status and problems of molecular target therapy for colorectal cancer.

Tsuda T, Nakajima T, Boku N. Tsuda T, et al. Among authors: boku n. Nihon Shokakibyo Gakkai Zasshi. 2011 Jan;108(1):19-23. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21212591 Review. No abstract available.

2

[New evidence of chemotherapy for gastrointestinal cancer].

Boku N. Boku N. Nihon Shokakibyo Gakkai Zasshi. 2008 Jul;105(7):987-93. Nihon Shokakibyo Gakkai Zasshi. 2008. PMID: 18603843 Review. Japanese. No abstract available.

3

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: boku n. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

4

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.

Satoh T, Yamada Y, Muro K, Hayashi H, Shimada Y, Takahari D, Taku K, Nakajima TE, Shi X, Brown KH, Boku N. Satoh T, et al. Among authors: boku n. Cancer Chemother Pharmacol. 2012 Feb;69(2):439-46. doi: 10.1007/s00280-011-1723-8. Epub 2011 Aug 19. Cancer Chemother Pharmacol. 2012. PMID: 21853311 Clinical Trial.

5

[Molecular target for Her2 positive gastric cancer].

Boku N. Boku N. Nihon Shokakibyo Gakkai Zasshi. 2012 Dec;109(12):2014-20. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 23221049 Review. Japanese. No abstract available.

6

Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients.

Boku N, Sugihara K, Kitagawa Y, Hatake K, Gemma A, Yamazaki N, Muro K, Hamaguchi T, Yoshino T, Yana I, Ueno H, Ohtsu A. Boku N, et al. Jpn J Clin Oncol. 2014 Mar;44(3):214-23. doi: 10.1093/jjco/hyt196. Epub 2014 Feb 12. Jpn J Clin Oncol. 2014. PMID: 24526771 Free PMC article. Clinical Trial.

7

[Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer].

Shigefuku R, Takahashi H, Tsuda T, Ikeda H, Matsunaga K, Matsumoto N, Okuse C, Boku N, Itoh F, Suzuki M. Shigefuku R, et al. Among authors: boku n. Nihon Shokakibyo Gakkai Zasshi. 2014 Dec;111(12):2326-36. Nihon Shokakibyo Gakkai Zasshi. 2014. PMID: 25482909 Japanese.

8

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.

Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.

9

EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.

Mizukami T, Togashi Y, Sogabe S, Banno E, Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Nakajima TE, Boku N, Nishio K. Mizukami T, et al. Among authors: boku n. Int J Oncol. 2015 Aug;47(2):499-505. doi: 10.3892/ijo.2015.3050. Epub 2015 Jun 16. Int J Oncol. 2015. PMID: 26081723

10

Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.

Horie Y, Yamazaki K, Funakoshi T, Hamauchi S, Taniguchi H, Tsushima T, Todaka A, Machida N, Taku K, Fukutomi A, Onozawa Y, Yasui H, Mizukami T, Izawa N, Hirakawa M, Tsuda T, Nakajima T, Boku N. Horie Y, et al. Among authors: boku n. Mol Clin Oncol. 2015 Sep;3(5):1029-1034. doi: 10.3892/mco.2015.586. Epub 2015 Jun 24. Mol Clin Oncol. 2015. PMID: 26623045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters